Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
- Top-line data with unexpected results requiring further clarification, did not meet primary endpoint as per protocol - Potent growth hormone release following macimorelin stimulation - Safety of...
Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024 Company ended the quarter with US$27.8...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.18 | 3.26086956522 | 5.52 | 5.7 | 5.29 | 982 | 5.54728732 | CS |
| 4 | -2.3 | -28.75 | 8 | 8.54 | 4.84 | 2145 | 5.60075227 | CS |
| 12 | -2.7 | -32.1428571429 | 8.4 | 9 | 4.84 | 2023 | 6.20224519 | CS |
| 26 | -2.7 | -32.1428571429 | 8.4 | 9 | 4.84 | 2023 | 6.20224519 | CS |
| 52 | -2.7 | -32.1428571429 | 8.4 | 9 | 4.84 | 2023 | 6.20224519 | CS |
| 156 | -2.7 | -32.1428571429 | 8.4 | 9 | 4.84 | 2023 | 6.20224519 | CS |
| 260 | -2.7 | -32.1428571429 | 8.4 | 9 | 4.84 | 2023 | 6.20224519 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
